1. Home
  2. NVO vs WFC Comparison

NVO vs WFC Comparison

Compare NVO & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • WFC
  • Stock Information
  • Founded
  • NVO 1923
  • WFC 1852
  • Country
  • NVO Denmark
  • WFC United States
  • Employees
  • NVO N/A
  • WFC N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • WFC Major Banks
  • Sector
  • NVO Health Care
  • WFC Finance
  • Exchange
  • NVO Nasdaq
  • WFC Nasdaq
  • Market Cap
  • NVO 278.0B
  • WFC 248.8B
  • IPO Year
  • NVO N/A
  • WFC N/A
  • Fundamental
  • Price
  • NVO $67.23
  • WFC $78.85
  • Analyst Decision
  • NVO Buy
  • WFC Buy
  • Analyst Count
  • NVO 3
  • WFC 16
  • Target Price
  • NVO $112.00
  • WFC $80.77
  • AVG Volume (30 Days)
  • NVO 7.7M
  • WFC 18.8M
  • Earning Date
  • NVO 08-06-2025
  • WFC 07-15-2025
  • Dividend Yield
  • NVO 1.76%
  • WFC 2.03%
  • EPS Growth
  • NVO 17.93
  • WFC 19.54
  • EPS
  • NVO 3.40
  • WFC 5.82
  • Revenue
  • NVO $43,922,211,349.00
  • WFC $77,618,000,000.00
  • Revenue This Year
  • NVO $18.59
  • WFC $7.90
  • Revenue Next Year
  • NVO $15.61
  • WFC $5.04
  • P/E Ratio
  • NVO $19.76
  • WFC $13.54
  • Revenue Growth
  • NVO 24.11
  • WFC N/A
  • 52 Week Low
  • NVO $57.00
  • WFC $50.15
  • 52 Week High
  • NVO $143.49
  • WFC $83.95
  • Technical
  • Relative Strength Index (RSI)
  • NVO 39.83
  • WFC 49.36
  • Support Level
  • NVO $68.65
  • WFC $81.43
  • Resistance Level
  • NVO $71.75
  • WFC $83.52
  • Average True Range (ATR)
  • NVO 1.50
  • WFC 1.46
  • MACD
  • NVO -0.32
  • WFC -0.14
  • Stochastic Oscillator
  • NVO 10.32
  • WFC 18.07

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About WFC Wells Fargo & Company

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US

Share on Social Networks: